Skip to main content

Events

Scinai Regains Nasdaq Compliance on $1.00 Minimum Bid Price Rule

Image
Scinai Regains Nasdaq Compliance on $1.00 Minimum Bid Price Rule

Jerusalem – September 21, 2026 -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) has regained compliance with Nasdaq's $1.00 minimum bid price rule after its American Depositary Shares closed at or above that threshold for 19 consecutive business days, Nasdaq Listing Qualifications confirmed in a September 18, 2026 letter.

Nasdaq closes compliance matter after ADS price clears threshold for 19 sessions

The closing bid price of Scinai's ADSs met or exceeded $1.00 per share from August 21, 2026 through September 17, 2026, satisfying Nasdaq Listing Rule 5550(a)(2). Nasdaq had first flagged the deficiency on March 12, 2026, after the ADSs failed to maintain the $1.00 minimum over the prior 30 consecutive business days.

CEO says resolution shifts focus to CDMO commercial execution

"Receiving Nasdaq's confirmation closes an important compliance matter for Scinai,

FDA Grants Priority Review to Insmed's ARIKAYCE Full Approval Bid

Image
FDA Grants Priority Review to Insmed's ARIKAYCE Full Approval Bid

Bridgewater, N.J. – September 21, 2026 -- The U.S. Food and Drug Administration has accepted Insmed Incorporated's supplemental New Drug Application (sNDA) for full approval of ARIKAYCE (amikacin liposome inhalation suspension) to treat Mycobacterium avium complex (MAC) lung disease, granting Priority Review with a PDUFA target action date of January 28, 2027.

FDA sets January 28, 2027 decision date under Priority Review

The Priority Review designation applies to therapies that could offer significant improvement in safety or efficacy for serious conditions. Insmed said full approval would allow ARIKAYCE, administered via PARI Pharma's Lamira Nebulizer System, to reach patients earlier in their disease course, including newly diagnosed cases and those with recurrent infections.

FDA Grants Platform Designation to Precigen's AdenoVerse Tech

Image
FDA Grants Platform Designation to Precigen's AdenoVerse Tech

Germantown, Md. – September 21, 2026 -- The U.S. Food and Drug Administration has granted platform technology designation to Precigen's AdenoVerse immunotherapeutic platform, the technology underlying the company's first commercial product, PAPZIMEOS, approved in August 2025 for recurrent respiratory papillomatosis (RRP) in adults.

FDA designation opens accelerated pathway for future AdenoVerse cancer programs

The designation allows Precigen to leverage manufacturing and preclinical data generated for PAPZIMEOS to support future marketing applications for other AdenoVerse-based candidates, reducing duplicative development work. It also grants the company earlier and more frequent FDA engagement and allows regulators to consider prior manufacturing inspections when reviewing future applications.

Fluxnium Raises $7M to Extract Uranium From Seawater

Image
Fluxnium Raises $7M to Extract Uranium From Seawater

Los Angeles – September 21, 2026 -- Fluxnium, Inc. has closed a $7 million seed round led by Congruent Ventures to commercialize technology that adsorbs uranium directly from seawater, targeting a domestic alternative to mined ore for nuclear fuel supply. Constellation Technology Ventures, the venture arm of Constellation (NASDAQ: CEG), and Active Impact Investments, Canada's largest climate tech seed fund, also participated in the round.

Seawater holds roughly 1,000 times more uranium than all identified land deposits combined

Fluxnium's proprietary high-surface-area fiber, developed in partnership with a U.S. national laboratory, passively captures dissolved uranium as seawater flows through it. The fiber deploys on longline systems in open water, the same passive infrastructure used in commercial seaweed and mussel farming, then is retrieved, processed and redeployed.

enCore Energy Hires North Star for IR, Sets Verdera Share Spinoff

Image
enCore Energy Hires North Star for IR, Sets Verdera Share Spinoff

Dallas – September 21, 2026 -- enCore Energy Corp. (NASDAQ, TSXV: EU) has engaged North Star Investor Relations Inc. under a consulting agreement effective September 18, 2026, paying a monthly cash retainer of CAD $10,000 for shareholder outreach, capital markets intelligence and media coordination.

North Star retainer runs for one year with a 30-day termination clause

The initial term of the Consulting Agreement is one year, renewable by mutual agreement, and either party may terminate on 30 days' written notice. North Star is owned by Graham Farrell and operates from Toronto; the firm and its principals are at arm's length to enCore and held no company securities when the agreement was signed. The engagement remains subject to TSXV approval.

Vylor, Rainbow Crops Partner on AI-Driven Corn Gene Editing

Image
Vylor, Rainbow Crops Partner on AI-Driven Corn Gene Editing

Johnston, Iowa and Ghent, Belgium – September 21, 2026 -- Vylor, the seed and genetics company set to spin off from Corteva on October 1, 2026, has partnered with Belgium's Rainbow Crops to develop climate-resilient corn traits using AI-driven multiplex gene editing.

Rainbow Crops' Trait Foundry platform edits hundreds of genes simultaneously

The collaboration will deploy Rainbow Crops' AI-supported Trait Foundry™ technology, which combines multiplex genome editing, precision breeding and automated phenotyping to accelerate development of corn hybrids resistant to heat, drought and flooding. Mat Muller, who will lead Vylor Edge, Vylor's investment arm, said the platform allows scientists to make hundreds of gene edits simultaneously while validating performance through phenotyping facilities and field trials.

FutureSports, MLB Ink Deal for CME Baseball Futures Indexes

Image
FutureSports, MLB Ink Deal for CME Baseball Futures Indexes

Chicago – September 21, 2026 -- FutureSports has signed an exclusive agreement with Major League Baseball to build rules-based performance indexes on all 30 MLB clubs, clearing the path for CME Group to list cash-settled futures contracts tied to the sport for the first time.

MLB Data Feeds New CME FSPI Benchmarks Covering All 30 Clubs

Under the agreement, MLB will supply FutureSports with Official League Data, which the index administrator will convert into CME FutureSports Performance Indexes (FSPI) tracking cumulative team performance. CME Group plans to list weekly, monthly and quarterly cash-settled futures contracts on the benchmarks, subject to regulatory review.

McDermott Completes $1.05 Billion Refinancing, Rights Offer 97% Subscribed

Image
McDermott Completes $1.05 Billion Refinancing, Rights Offer 97% Subscribed

Houston – September 21, 2026 -- McDermott International, Ltd has completed a comprehensive refinancing package worth more than $1 billion, combining a $500 million equity rights offering, a $550 million senior secured Nordic bond and a new long-term letter of credit facility.

Rights offering draws 97% shareholder subscription

The $500 million equity financing was structured as a rights offering to existing shareholders and was 97% subscribed by Class A ordinary shareholders. Remaining shares were absorbed through related backstop commitments, ensuring full completion of the raise.

Nordic bond matures in 2031, extends debt maturity profile

McDermott issued $550 million in senior secured bonds in the Nordic market, with maturity set for 2031. The company also secured a new long-term letter of credit and guarantee facility, alongside a revolving credit facility, as part of the same transaction.

Bloomberg TV's 'Advancements' Spotlights Construction AI, Open Automation

Jupiter, Fla. – September 21, 2026 -- Bloomberg Television will broadcast a new episode of "Advancements with Ted Danson" on Saturday, September 26, 2026, at 8:00 p.m. ET, featuring four segments on construction technology, food packaging recyclability, continuous healthcare, and industrial automation.

Construction industry adopts AI and automation to accelerate megaproject delivery

The episode opens by examining how demand for semiconductor fabrication plants, clean energy projects, and transportation infrastructure is pushing the construction sector to build faster and at greater scale. The segment features Bechtel and shows how artificial intelligence, automation, and project data tools are being deployed to support craft professionals, engineers, and project managers.

Rubber Process Oil Market to Hit $3.94B by 2031, MarketsandMarkets Says

Image
Rubber Process Oil Market to Hit $3.94B by 2031, MarketsandMarkets Says

Delray Beach, Fla. – September 21, 2026 -- The global rubber process oil (RPO) market is set to expand from $3.30 billion in 2026 to $3.94 billion by 2031, growing at a compound annual growth rate of 3.6%, according to a new report from MarketsandMarkets.

Tire manufacturing drives largest share of oil demand

The tires application segment is projected to register the highest growth at 4.7% CAGR and remains the largest consumer of RPO by value. Manufacturers rely on process oils to balance flexibility, durability, and processing efficiency across passenger, commercial, and specialty tire production. Rising replacement-tire demand and evolving fuel-efficiency standards are reinforcing this consumption base.

YeahPay Expands Online Merchant Acquiring to Seven Global Markets

Hong Kong – September 21, 2026 -- Yeahka Limited (9923.HK) announced that YeahPay, its international payment arm, has expanded online merchant acquiring to seven markets through infrastructure built on Stripe. Businesses incorporated in Australia, Canada, Hong Kong SAR, Japan, Singapore, the United Kingdom and the United States can now be onboarded directly by YeahPay for online acquiring in their home market.

YeahPay unifies online and in-store payment acceptance for the first time

The company already provides in-store payment acceptance in Hong Kong SAR and Singapore. The latest expansion merges those in-store capabilities with online acquiring on a single integration, drawing on more than a decade of experience building payment acceptance for small and medium merchants across mainland China.

XCMG Launches Hanjing Heavy Truck, Leads China's NEV Truck Market

Image
XCMG Launches Hanjing Heavy Truck, Leads China's NEV Truck Market

Xuzhou – September 21, 2026 -- XCMG launched the Hanjing, its next-generation new energy heavy truck for long-haul freight, on Sept. 20, positioning the vehicle to compete on range, charging speed and lifecycle operating costs against diesel incumbents.

800-volt architecture cuts charging time to under 20 minutes

The Hanjing's 800-volt architecture supports megawatt-class fast charging, taking the battery from 20% to 80% capacity in under 20 minutes. The truck pairs a low-drag cab with a proprietary integrated electric drive axle and intelligent controls aimed at reducing energy consumption on cross-regional routes.

Huawei Launches Fintelligent AI Solution to Scale Agentic Banking

Image
Huawei Launches Fintelligent AI Solution to Scale Agentic Banking

Shanghai – September 21, 2026 -- Huawei has launched its Fintelligent AI Solution worldwide, targeting the security, scalability, and sustainability barriers that have limited large-scale AI deployment across the global financial industry.

The announcement came at the Global Finance Summit held during HUAWEI CONNECT 2026, where Jason Cao, CEO of Huawei's Digital Finance BU, delivered a keynote titled "Owning Your AI, Advancing Agentic Banking." Cao told financial customers that competition in financial AI is shifting from model capability to enterprise-wide AI system capability, and that institutions must be able to choose, operate, replicate, and evolve their AI independently rather than relying on isolated applications or single vendor models.

ITRI Launches 3.2T Silicon Photonics Engine, Rallies 20+ Partners at TIE 2026

Image
ITRI Launches 3.2T Silicon Photonics Engine, Rallies 20+ Partners at TIE 2026

Taipei – September 21, 2026 -- Taiwan's Industrial Technology Research Institute (ITRI) has unveiled a 3.2 Tbps silicon photonics optical engine capable of moving roughly 400 GB of data per second, doubling the throughput of its previous 1.6T generation.

ITRI mobilizes 20+ partners to commercialize 3.2T optical technology

The technology was showcased at the Innovation Economy Pavilion of the Taiwan Innotech Expo (TIE) 2026, held at the Taipei World Trade Center Exhibition Hall 1, where the Department of Industrial Technology (DoIT) under the Ministry of Economic Affairs presented 64 technologies from more than 13 research institutes and industry partners. To push the 3.2T engine toward commercial deployment, ITRI has built a supply chain network of more than 20 partners covering chip design, fabrication, testing and packaging, and has worked with international firms to align technical specifications for the standard.

VNET Closes Deal, CATL-Linked Investor Takes 38.1% Stake

Beijing – September 21, 2026 -- VNET Group, Inc. (Nasdaq: VNET) has completed the transfer of 650,424,192 Class A ordinary shares to two investment vehicles linked to Contemporary Amperex Technology Co., Limited (CATL), giving the buyers a combined 38.1% stake in the Chinese data center operator.

PJ Millennium entities acquire majority-scale stake from prior shareholders

PJ Millennium I Limited and PJ Millennium II Limited purchased the shares from Success Flow International Investment Limited and Choice Faith Group Holdings Limited. Both buyers are wholly owned subsidiaries of PJ Millennium Limited Partnership, whose general partner, Lochpine BG I GP Limited, sits under Lochpine Capital Limited -- a non-controlled, non-consolidated affiliate of CATL (300750.SZ, 03750.HK).

Arctech Wins EcoVadis Silver, Ranks in Top 15% Globally

Image
Arctech Wins EcoVadis Silver, Ranks in Top 15% Globally

Kunshan – September 21, 2026 -- Arctech has been awarded a Silver Medal in the 2026 EcoVadis Sustainability Rating, placing the solar tracker maker among the top 15% of companies assessed by EcoVadis worldwide.

EcoVadis scores companies across four sustainability pillars

The rating agency evaluates firms on Environment, Labor & Human Rights, Ethics, and Sustainable Procurement, ranking medal recipients by percentile against all companies assessed globally over the prior 12 months. Arctech's Silver Medal corresponds to the top 15% tier.

Arctech spent RMB 4.3629 million on environmental protection in 2025

That figure, approximately US$651,000, funded initiatives tied to the company's environmental performance improvements. Its self-owned photovoltaic power stations generated more than 34 million kWh of electricity, covering 24% of Arctech's total electricity consumption.

WuXi XDC Wins GMP Release for First Overseas Site in Singapore

Image
WuXi XDC Wins GMP Release for First Overseas Site in Singapore

Singapore – September 21, 2026 -- WuXi XDC Cayman Inc. (2268.HK) has secured GMP release for its Singapore manufacturing site at Tuas Biomedical Park, marking the bioconjugate CRDMO's first overseas facility just two and a half years after the site was announced in March 2024.

BCM3 dual-function line and DP4 drug product facility clear GMP release

The 25,000-square-meter site achieved GMP release for both its BCM3 antibody intermediate and conjugated drug substance production line and its DP4 drug product facility in August 2026. BCM3 supports batch sizes from 200 L to 2,000 L for antibody intermediates and up to 2,000 L for conjugated drug substances, operating under FDA, EMA and NMPA standards. A second line, BCM4, is slated for GMP release by the end of 2026 with a maximum single-batch capacity of 500 L for conjugated drug substance.

SirPAD Trial Subgroup Data on Sirolimus Balloon Set for VIVA 2026

Image
SirPAD Trial Subgroup Data on Sirolimus Balloon Set for VIVA 2026

Las Vegas – September 21, 2026 -- Concept Medical's MagicTouch sirolimus-coated balloon will face fresh scrutiny at VIVA 2026 as researchers unveil new subgroup data from the SirPAD randomized trial covering 597 patients treated for femoropopliteal peripheral artery disease without tissue loss.

SirPAD enrolled 1,252 patients to compare drug-coated and uncoated balloon angioplasty

The academic, investigator-initiated trial randomized 1,252 patients with symptomatic infrainguinal peripheral artery disease to angioplasty using either the MagicTouch PTA sirolimus-coated balloon or an uncoated balloon. Primary results, published in the New England Journal of Medicine, showed the sirolimus-coated balloon arm was both non-inferior and superior to the uncoated balloon on major adverse limb events (MALE) at one year.

Grünenthal Buys Bayer's Stivarga in Deal Worth Up to €375M

Image
Grünenthal Buys Bayer's Stivarga in Deal Worth Up to €375M

Aachen, Germany – September 21, 2026 -- Grünenthal has agreed to acquire Bayer AG's oncology drug Stivarga® (regorafenib) for up to €375 million, adding an oral cancer treatment sold in more than 90 markets to its portfolio.

Grünenthal expects Stivarga to add up to €100 million to EBITDA in 2027

The German pharmaceutical company said the acquisition is immediately accretive to its business, with an estimated positive impact on consolidated EBITDA of approximately €100 million for the year ending December 31, 2027. That projection assumes the deal closes by the end of 2026 or early 2027 and includes a full year of consolidation.

Huawei Unveils Intelligent WAN Architecture for ISP AI Services

Image
Huawei Unveils Intelligent WAN Architecture for ISP AI Services

Shanghai – September 21, 2026 -- Huawei unveiled its Intelligent WAN Target Architecture on September 17 at HUAWEI CONNECT 2026, targeting internet service providers seeking to monetize AI-driven connectivity demand.

Huawei ties network architecture to AI monetization strategy

Speaking at a roundtable titled "Intelligent WAN, Fortifying the AI Services Connectivity Foundation for ISPs," Wayne Zhou, Vice President of Huawei's ISP Computing and Network Infrastructure BU, said asset-heavy ISPs can convert connectivity capabilities into lightweight AI services as AI commercialization accelerates. He said ISPs are shifting from selling bandwidth to delivering AI services by combining edge nodes, computing, and APIs.